Mary C. Casey

439 total citations
20 papers, 337 citations indexed

About

Mary C. Casey is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Mary C. Casey has authored 20 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 11 papers in Virology and 8 papers in Hepatology. Recurrent topics in Mary C. Casey's work include HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (11 papers) and Hepatitis C virus research (6 papers). Mary C. Casey is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (11 papers) and Hepatitis C virus research (6 papers). Mary C. Casey collaborates with scholars based in United States, Japan and China. Mary C. Casey's co-authors include Stefan G. Sarafianos, Zhengqiang Wang, Karen A. Kirby, Jayakanth Kankanala, Andrew D. Huber, Daniel J. Wilson, Jing Tang, Jiashu Xie, Lei Wang and Sanjeev Kumar V. Vernekar and has published in prestigious journals such as PEDIATRICS, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Mary C. Casey

18 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary C. Casey United States 13 242 204 144 74 55 20 337
Jérôme Deval United States 8 237 1.0× 114 0.6× 146 1.0× 118 1.6× 35 0.6× 13 402
Dorothée Bardiot Belgium 6 310 1.3× 256 1.3× 247 1.7× 60 0.8× 103 1.9× 9 505
Deborah J. Woolf United States 4 275 1.1× 247 1.2× 208 1.4× 44 0.6× 37 0.7× 5 387
Florian Leidner United States 11 144 0.6× 96 0.5× 116 0.8× 46 0.6× 26 0.5× 16 260
Marcia Van Ginderen Belgium 6 336 1.4× 284 1.4× 135 0.9× 109 1.5× 17 0.3× 6 387
Maxwell D. Leslie United States 9 250 1.0× 218 1.1× 75 0.5× 96 1.3× 21 0.4× 11 313
Murty N. Arimilli United States 8 242 1.0× 152 0.7× 142 1.0× 147 2.0× 47 0.9× 9 410
Peggy Geluykens Belgium 7 241 1.0× 194 1.0× 126 0.9× 91 1.2× 16 0.3× 10 345
Brenda I. Hernández-Santiago United States 9 307 1.3× 114 0.6× 143 1.0× 167 2.3× 39 0.7× 16 451
Ruby Cai United States 9 162 0.7× 82 0.4× 85 0.6× 186 2.5× 62 1.1× 9 349

Countries citing papers authored by Mary C. Casey

Since Specialization
Citations

This map shows the geographic impact of Mary C. Casey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary C. Casey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary C. Casey more than expected).

Fields of papers citing papers by Mary C. Casey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary C. Casey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary C. Casey. The network helps show where Mary C. Casey may publish in the future.

Co-authorship network of co-authors of Mary C. Casey

This figure shows the co-authorship network connecting the top 25 collaborators of Mary C. Casey. A scholar is included among the top collaborators of Mary C. Casey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary C. Casey. Mary C. Casey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burke, Rachel M., Daniel C. Payne, Monica McNeal, et al.. (2024). Correlates of Rotavirus Vaccine Shedding and Seroconversion in a US Cohort of Healthy Infants. The Journal of Infectious Diseases. 230(3). 754–762. 4 indexed citations
2.
Casey, Mary C., Grant A. L. Bare, Karen A. Kirby, et al.. (2024). Identification of clickable HIV-1 capsid-targeting probes for viral replication inhibition. Cell chemical biology. 31(3). 477–486.e7. 7 indexed citations
3.
Cortese, Margaret M., Kevin O’Callaghan, Mary C. Casey, et al.. (2024). Risk of Transmission of Vaccine-Strain Rotavirus in a Neonatal Intensive Care Unit That Routinely Vaccinates. PEDIATRICS. 155(1).
4.
Kumar, Deepak, Nora L. Springer, Gleyder Román‐Sosa, et al.. (2023). Role of Pre-Farrow Natural Planned Exposure of Gilts in Shaping the Passive Antibody Response to Rotavirus A in Piglets. Vaccines. 11(12). 1866–1866. 1 indexed citations
5.
Casey, Mary C., et al.. (2023). Coding-complete genome sequences of rotavirus A reference strains EDIM, Ph158, and CC425. Microbiology Resource Announcements. 12(11). e0063023–e0063023.
6.
Sahani, Rajkumar Lalji, Sanjeev Kumar V. Vernekar, Lei Wang, et al.. (2021). Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74. Viruses. 13(3). 479–479. 12 indexed citations
7.
Wang, Lei, Mary C. Casey, Sanjeev Kumar V. Vernekar, et al.. (2020). Novel HIV-1 capsid-targeting small molecules of the PF74 binding site. European Journal of Medicinal Chemistry. 204. 112626–112626. 19 indexed citations
8.
Wang, Lei, Mary C. Casey, Sanjeev Kumar V. Vernekar, et al.. (2020). Chemical profiling of HIV-1 capsid-targeting antiviral PF74. European Journal of Medicinal Chemistry. 200. 112427–112427. 21 indexed citations
9.
Liu, Dandan, Maritza Puray‐Chavez, Mary C. Casey, et al.. (2020). Effect of P‐body component Mov10 on HCV virus production and infectivity. The FASEB Journal. 34(7). 9433–9449. 12 indexed citations
10.
Wang, Lei, Mary C. Casey, Sanjeev Kumar V. Vernekar, et al.. (2020). Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability. Acta Pharmaceutica Sinica B. 11(3). 810–822. 25 indexed citations
11.
Vernekar, Sanjeev Kumar V., Rajkumar Lalji Sahani, Mary C. Casey, et al.. (2020). Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules. Viruses. 12(4). 452–452. 25 indexed citations
12.
Tang, Jing, Ha T., Andrew D. Huber, et al.. (2019). Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker. European Journal of Medicinal Chemistry. 166. 390–399. 20 indexed citations
13.
Puray‐Chavez, Maritza, Andrew D. Huber, Dandan Liu, et al.. (2019). Effects of Moloney Leukemia Virus 10 Protein on Hepatitis B Virus Infection and Viral Replication. Viruses. 11(7). 651–651. 10 indexed citations
14.
Wang, Lei, Jing Tang, Andrew D. Huber, et al.. (2018). 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity. European Journal of Medicinal Chemistry. 156. 652–665. 27 indexed citations
15.
Wang, Lei, Jing Tang, Andrew D. Huber, et al.. (2018). 6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H. European Journal of Medicinal Chemistry. 156. 680–691. 23 indexed citations
16.
Kankanala, Jayakanth, Karen A. Kirby, Andrew D. Huber, et al.. (2017). Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H. European Journal of Medicinal Chemistry. 141. 149–161. 37 indexed citations
17.
Tang, Jing, Karen A. Kirby, Andrew D. Huber, et al.. (2017). 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase. European Journal of Medicinal Chemistry. 128. 168–179. 20 indexed citations
18.
Vernekar, Sanjeev Kumar V., Jing Tang, Bulan Wu, et al.. (2017). Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. Journal of Medicinal Chemistry. 60(12). 5045–5056. 36 indexed citations
19.
Wu, Bulan, Jing Tang, Daniel J. Wilson, et al.. (2016). 3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H. Journal of Medicinal Chemistry. 59(13). 6136–6148. 36 indexed citations
20.
Thomas, Leo A., C. M. Eklund, Robert N. Philip, & Mary C. Casey. (1963). Development of a Vaccine Against Colorado Tick Fever for Use in Man. American Journal of Tropical Medicine and Hygiene. 12(4). 678–685. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jérôme Deval Breakdown of academic impact, for papers by Dorothée Bardiot Breakdown of academic impact, for papers by Deborah J. Woolf Breakdown of academic impact, for papers by Florian Leidner Breakdown of academic impact, for papers by Marcia Van Ginderen Breakdown of academic impact, for papers by Maxwell D. Leslie Breakdown of academic impact, for papers by Murty N. Arimilli Breakdown of academic impact, for papers by Peggy Geluykens Breakdown of academic impact, for papers by Brenda I. Hernández-Santiago Breakdown of academic impact, for papers by Ruby Cai
Rankless by CCL
2026